Annual CFF
-$48.92 M
+$38.60 M+44.10%
December 31, 2024
Summary
- As of March 12, 2025, AMED annual cash flow from financing activities is -$48.92 million, with the most recent change of +$38.60 million (+44.10%) on December 31, 2024.
- During the last 3 years, AMED annual CFF has fallen by -$104.05 million (-188.75%).
- AMED annual CFF is now -116.22% below its all-time high of $301.57 million, reached on December 31, 2008.
Performance
AMED Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$11.21 M
+$3.88 M+25.73%
December 31, 2024
Summary
- As of March 12, 2025, AMED quarterly cash flow from financing activities is -$11.21 million, with the most recent change of +$3.88 million (+25.73%) on December 31, 2024.
- Over the past year, AMED quarterly CFF has increased by +$2.22 million (+16.54%).
- AMED quarterly CFF is now -102.91% below its all-time high of $385.21 million, reached on March 31, 2008.
Performance
AMED Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
-$48.92 M
+$2.22 M+4.34%
December 31, 2024
Summary
- As of March 12, 2025, AMED TTM cash flow from financing activities is -$48.92 million, with the most recent change of +$2.22 million (+4.34%) on December 31, 2024.
- Over the past year, AMED TTM CFF has increased by +$38.60 million (+44.10%).
- AMED TTM CFF is now -112.63% below its all-time high of $387.46 million, reached on March 31, 2008.
Performance
AMED TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
AMED Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +44.1% | +16.5% | +44.1% |
| 3 y3 years | -188.8% | +16.5% | +44.1% |
| 5 y5 years | -121.5% | +16.5% | +44.1% |
AMED Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -188.8% | +44.1% | -324.3% | +85.2% | -132.4% | +45.9% |
| 5 y | 5-year | -121.5% | +44.1% | -104.7% | +92.4% | -121.5% | +86.0% |
| alltime | all time | -116.2% | +81.7% | -102.9% | +92.4% | -112.6% | +86.0% |
Amedisys Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$48.92 M(-44.1%) | -$11.21 M(-25.7%) | -$48.92 M(-4.3%) |
| Sep 2024 | - | -$15.09 M(+7.2%) | -$51.14 M(+20.9%) |
| Jun 2024 | - | -$14.08 M(+64.7%) | -$42.31 M(+8.0%) |
| Mar 2024 | - | -$8.55 M(-36.3%) | -$39.18 M(-55.2%) |
| Dec 2023 | -$87.52 M(+187.6%) | -$13.43 M(+114.7%) | -$87.52 M(-3.2%) |
| Sep 2023 | - | -$6.25 M(-42.9%) | -$90.44 M(+4.2%) |
| Jun 2023 | - | -$10.95 M(-80.7%) | -$86.83 M(+8.6%) |
| Mar 2023 | - | -$56.89 M(+248.1%) | -$79.92 M(+162.6%) |
| Dec 2022 | -$30.43 M(-155.2%) | -$16.34 M(+518.9%) | -$30.43 M(-66.2%) |
| Sep 2022 | - | -$2.64 M(-34.7%) | -$90.03 M(-159.6%) |
| Jun 2022 | - | -$4.05 M(-45.3%) | $150.97 M(+43.5%) |
| Mar 2022 | - | -$7.40 M(-90.3%) | $105.18 M(+90.8%) |
| Dec 2021 | $55.13 M(-468.1%) | -$75.94 M(-131.9%) | $55.13 M(+59.2%) |
| Sep 2021 | - | $238.36 M(-578.3%) | $34.62 M(-109.9%) |
| Jun 2021 | - | -$49.83 M(-13.3%) | -$350.47 M(+60.4%) |
| Mar 2021 | - | -$57.46 M(-40.4%) | -$218.48 M(+1358.8%) |
| Dec 2020 | -$14.98 M(-106.6%) | -$96.44 M(-34.3%) | -$14.98 M(-118.0%) |
| Sep 2020 | - | -$146.74 M(-278.6%) | $83.36 M(-56.8%) |
| Jun 2020 | - | $82.16 M(-43.7%) | $193.10 M(+160.7%) |
| Mar 2020 | - | $146.04 M(+7590.5%) | $74.07 M(-67.4%) |
| Dec 2019 | $227.21 M(-185.0%) | $1.90 M(-105.1%) | $227.21 M(+28.3%) |
| Sep 2019 | - | -$37.00 M(+0.3%) | $177.07 M(+25.5%) |
| Jun 2019 | - | -$36.87 M(-112.3%) | $141.11 M(+301.1%) |
| Mar 2019 | - | $299.18 M(-720.2%) | $35.18 M(-113.2%) |
| Dec 2018 | -$267.42 M(+4728.9%) | -$48.24 M(-33.9%) | -$267.42 M(+21.6%) |
| Sep 2018 | - | -$72.96 M(-48.9%) | -$219.99 M(+47.8%) |
| Jun 2018 | - | -$142.80 M(+4063.1%) | -$148.84 M(+1718.9%) |
| Mar 2018 | - | -$3.43 M(+322.9%) | -$8.18 M(+47.8%) |
| Dec 2017 | -$5.54 M(-26.3%) | -$811.00 K(-55.0%) | -$5.54 M(+3.4%) |
| Sep 2017 | - | -$1.80 M(-15.9%) | -$5.36 M(+42.4%) |
| Jun 2017 | - | -$2.14 M(+172.7%) | -$3.76 M(-64.3%) |
| Mar 2017 | - | -$785.00 K(+24.6%) | -$10.53 M(+40.1%) |
| Dec 2016 | -$7.51 M(-64.0%) | -$630.00 K(+204.3%) | -$7.51 M(-15.7%) |
| Sep 2016 | - | -$207.00 K(-97.7%) | -$8.92 M(+18.5%) |
| Jun 2016 | - | -$8.91 M(-499.2%) | -$7.53 M(+458.7%) |
| Mar 2016 | - | $2.23 M(-209.9%) | -$1.35 M(-93.6%) |
| Dec 2015 | -$20.89 M(-129.6%) | -$2.03 M(-271.7%) | -$20.89 M(+32.0%) |
| Sep 2015 | - | $1.18 M(-143.3%) | -$15.83 M(-67.2%) |
| Jun 2015 | - | -$2.73 M(-84.2%) | -$48.27 M(-185.5%) |
| Mar 2015 | - | -$17.32 M(-670.9%) | $56.45 M(-20.0%) |
| Dec 2014 | $70.56 M(-233.0%) | $3.03 M(-109.7%) | $70.56 M(+61.1%) |
| Sep 2014 | - | -$31.25 M(-130.6%) | $43.81 M(-39.1%) |
| Jun 2014 | - | $101.99 M(-3286.1%) | $71.93 M(-317.1%) |
| Mar 2014 | - | -$3.20 M(-86.5%) | -$33.13 M(-37.5%) |
| Dec 2013 | -$53.05 M(+23.5%) | -$23.72 M(+656.4%) | -$53.05 M(+6.6%) |
| Sep 2013 | - | -$3.14 M(+2.0%) | -$49.77 M(-8.1%) |
| Jun 2013 | - | -$3.07 M(-86.7%) | -$54.13 M(-7.5%) |
| Mar 2013 | - | -$23.11 M(+13.1%) | -$58.49 M(+36.1%) |
| Dec 2012 | -$42.96 M(+31.0%) | -$20.45 M(+172.8%) | -$42.96 M(+48.9%) |
| Sep 2012 | - | -$7.50 M(+0.8%) | -$28.84 M(-6.0%) |
| Jun 2012 | - | -$7.43 M(-2.1%) | -$30.67 M(-5.2%) |
| Mar 2012 | - | -$7.59 M(+19.9%) | -$32.34 M(-1.4%) |
| Dec 2011 | -$32.79 M(-30.0%) | -$6.33 M(-32.1%) | -$32.79 M(-8.7%) |
| Sep 2011 | - | -$9.32 M(+2.4%) | -$35.91 M(-24.8%) |
| Jun 2011 | - | -$9.11 M(+13.3%) | -$47.78 M(+4.5%) |
| Mar 2011 | - | -$8.04 M(-15.0%) | -$45.71 M(-2.4%) |
| Dec 2010 | -$46.85 M(-60.6%) | -$9.45 M(-55.4%) | -$46.85 M(+5.7%) |
| Sep 2010 | - | -$21.19 M(+201.4%) | -$44.32 M(+0.3%) |
| Jun 2010 | - | -$7.03 M(-23.4%) | -$44.21 M(-60.3%) |
| Mar 2010 | - | -$9.18 M(+32.4%) | -$111.32 M(-6.3%) |
| Dec 2009 | -$118.77 M | -$6.93 M(-67.1%) | -$118.77 M(-16.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2009 | - | -$21.08 M(-71.6%) | -$141.75 M(+3.5%) |
| Jun 2009 | - | -$74.14 M(+346.2%) | -$136.93 M(+36.6%) |
| Mar 2009 | - | -$16.62 M(-44.4%) | -$100.26 M(-133.2%) |
| Dec 2008 | $301.57 M(+9300.5%) | -$29.91 M(+84.0%) | $301.57 M(-9.3%) |
| Sep 2008 | - | -$16.25 M(-56.6%) | $332.54 M(-4.6%) |
| Jun 2008 | - | -$37.48 M(-109.7%) | $348.74 M(-10.0%) |
| Mar 2008 | - | $385.21 M(>+9900.0%) | $387.46 M(>+9900.0%) |
| Dec 2007 | $3.21 M(-95.5%) | $1.06 M(-2130.8%) | $3.21 M(-95.8%) |
| Sep 2007 | - | -$52.00 K(-104.2%) | $77.20 M(+0.4%) |
| Jun 2007 | - | $1.25 M(+30.3%) | $76.93 M(+17.5%) |
| Mar 2007 | - | $957.00 K(-98.7%) | $65.47 M(-9.0%) |
| Dec 2006 | $71.97 M(+47.7%) | $75.05 M(<-9900.0%) | $71.97 M(-656.0%) |
| Sep 2006 | - | -$326.00 K(-96.8%) | -$12.94 M(-128.3%) |
| Jun 2006 | - | -$10.22 M(-236.9%) | $45.68 M(-19.0%) |
| Mar 2006 | - | $7.46 M(-175.7%) | $56.42 M(+15.8%) |
| Dec 2005 | $48.71 M(-25.8%) | -$9.86 M(-116.9%) | $48.71 M(-13.9%) |
| Sep 2005 | - | $58.30 M(>+9900.0%) | $56.58 M(-15.5%) |
| Jun 2005 | - | $518.00 K(-312.3%) | $66.92 M(+1.6%) |
| Mar 2005 | - | -$244.00 K(-87.8%) | $65.85 M(+0.2%) |
| Dec 2004 | $65.69 M(+473.4%) | -$2.00 M(-102.9%) | $65.69 M(-19.9%) |
| Sep 2004 | - | $68.64 M(<-9900.0%) | $81.97 M(+482.1%) |
| Jun 2004 | - | -$545.00 K(+33.9%) | $14.08 M(+11.3%) |
| Mar 2004 | - | -$407.00 K(-102.9%) | $12.65 M(+10.5%) |
| Dec 2003 | $11.46 M(-234.0%) | $14.28 M(+1788.4%) | $11.46 M(-220.3%) |
| Sep 2003 | - | $756.00 K(-138.4%) | -$9.53 M(-4.7%) |
| Jun 2003 | - | -$1.97 M(+22.7%) | -$9.99 M(+293.2%) |
| Mar 2003 | - | -$1.60 M(-76.1%) | -$2.54 M(-70.3%) |
| Dec 2002 | -$8.55 M(-179.4%) | -$6.71 M(-2404.8%) | -$8.55 M(-279.7%) |
| Sep 2002 | - | $291.00 K(-94.7%) | $4.76 M(-10.4%) |
| Jun 2002 | - | $5.48 M(-172.0%) | $5.32 M(-1576.4%) |
| Mar 2002 | - | -$7.62 M(-215.3%) | -$360.00 K(-103.3%) |
| Dec 2001 | $10.78 M(-231.7%) | $6.61 M(+680.7%) | $10.78 M(-404.9%) |
| Sep 2001 | - | $846.00 K(-533.8%) | -$3.53 M(-31.7%) |
| Jun 2001 | - | -$195.00 K(-105.5%) | -$5.17 M(+83.2%) |
| Mar 2001 | - | $3.52 M(-145.7%) | -$2.82 M(-65.5%) |
| Dec 2000 | -$8.18 M(-174.6%) | -$7.70 M(+872.7%) | -$8.18 M(+1611.7%) |
| Sep 2000 | - | -$792.00 K(-136.8%) | -$478.00 K(-252.2%) |
| Jun 2000 | - | $2.15 M(-217.1%) | $314.00 K(-117.1%) |
| Mar 2000 | - | -$1.84 M(-117.7%) | -$1.84 M(-165.3%) |
| Dec 1999 | $10.96 M(-250.2%) | - | - |
| Mar 1999 | - | $10.42 M(-161.6%) | $2.82 M(-138.6%) |
| Dec 1998 | -$7.30 M(-236.5%) | -$16.90 M(-381.6%) | -$7.30 M(-155.1%) |
| Sep 1998 | - | $6.00 M(+81.8%) | $13.25 M(+85.3%) |
| Jun 1998 | - | $3.30 M(+1000.0%) | $7.15 M(+53.8%) |
| Mar 1998 | - | $300.00 K(-91.8%) | $4.65 M(-13.1%) |
| Dec 1997 | $5.35 M(+37.8%) | $3.65 M(-3749.0%) | $5.35 M(+53.6%) |
| Sep 1997 | - | -$100.00 K(-112.5%) | $3.48 M(-5.4%) |
| Jun 1997 | - | $800.00 K(-20.0%) | $3.68 M(-7.5%) |
| Mar 1997 | - | $1.00 M(-43.9%) | $3.98 M(+2.6%) |
| Dec 1996 | $3.88 M(-1070.5%) | $1.78 M(+1682.0%) | $3.88 M(+21.3%) |
| Sep 1996 | - | $100.00 K(-90.9%) | $3.20 M(+39.1%) |
| Jun 1996 | - | $1.10 M(+22.2%) | $2.30 M(+283.3%) |
| Mar 1996 | - | $900.00 K(-18.2%) | $600.00 K(-250.0%) |
| Dec 1995 | -$400.00 K(-130.8%) | $1.10 M(-237.5%) | -$400.00 K(-73.3%) |
| Sep 1995 | - | -$800.00 K(+33.3%) | -$1.50 M(+114.3%) |
| Jun 1995 | - | -$600.00 K(+500.0%) | -$700.00 K(<-9900.0%) |
| Mar 1995 | - | -$100.00 K(-200.0%) | $0.00(-100.0%) |
| Dec 1994 | $1.30 M(0.0%) | - | - |
| Jun 1994 | - | $100.00 K(-80.0%) | $600.00 K(+20.0%) |
| Mar 1994 | - | $500.00 K | $500.00 K |
| Dec 1993 | $1.30 M | - | - |
FAQ
- What is Amedisys annual cash flow from financing activities?
- What is the all time high annual CFF for Amedisys?
- What is Amedisys annual CFF year-on-year change?
- What is Amedisys quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Amedisys?
- What is Amedisys quarterly CFF year-on-year change?
- What is Amedisys TTM cash flow from financing activities?
- What is the all time high TTM CFF for Amedisys?
- What is Amedisys TTM CFF year-on-year change?
What is Amedisys annual cash flow from financing activities?
The current annual CFF of AMED is -$48.92 M
What is the all time high annual CFF for Amedisys?
Amedisys all-time high annual cash flow from financing activities is $301.57 M
What is Amedisys annual CFF year-on-year change?
Over the past year, AMED annual cash flow from financing activities has changed by +$38.60 M (+44.10%)
What is Amedisys quarterly cash flow from financing activities?
The current quarterly CFF of AMED is -$11.21 M
What is the all time high quarterly CFF for Amedisys?
Amedisys all-time high quarterly cash flow from financing activities is $385.21 M
What is Amedisys quarterly CFF year-on-year change?
Over the past year, AMED quarterly cash flow from financing activities has changed by +$2.22 M (+16.54%)
What is Amedisys TTM cash flow from financing activities?
The current TTM CFF of AMED is -$48.92 M
What is the all time high TTM CFF for Amedisys?
Amedisys all-time high TTM cash flow from financing activities is $387.46 M
What is Amedisys TTM CFF year-on-year change?
Over the past year, AMED TTM cash flow from financing activities has changed by +$38.60 M (+44.10%)